» Articles » PMID: 21232882

Attitudes Toward Opioid Substitution Therapy and Pre-incarceration HIV Transmission Behaviors Among HIV-infected Prisoners in Malaysia: Implications for Secondary Prevention

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2011 Jan 15
PMID 21232882
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pre-incarceration HIV transmission behaviors and current attitudes toward opioid substitution therapy (OST) among HIV-infected male prisoners in Malaysia have important implications for secondary HIV prevention efforts.

Methods: In June 2007, 102 HIV-infected male prisoners within 6 months of community-release were anonymously surveyed in Kota Bharu, Malaysia.

Results: Nearly all subjects (95%) met criteria for opioid dependence. Overall, 66% of participants reported sharing needles, and 37% reported unprotected sex in the 30 days prior to incarceration. During this period, 77% reported injection drug use, with 71% injecting daily and 65% injecting more than one substance. Injection of buprenorphine (28%), benzodiazepines (28%) and methamphetamines (49%) was reported. Nearly all (97%) of those reporting unprotected sex did so with someone not known to be HIV-infected. While 51% believed that opioid substitution therapy (OST) would be helpful, only 33% believed they needed it to prevent relapse after prison release. Most participants (70%) expressed interest in learning more about OST. Those reporting the highest injection risks were more likely to believe OST would be helpful (p<0.05), to believe that it was needed to prevent relapse post-release (p<0.05), and to express interest in learning more about OST (p<0.01).

Conclusions: Secondary HIV prevention among prisoners in Malaysia is crucial to reduce community HIV transmission after release. Effectively reducing HIV risk associated with opioid injection will require OST expansion, including social marketing to improve its acceptability and careful monitoring. Access to sterile injection equipment, particularly for non-opioid injectors, and behavioral interventions that reduce sexual risk will also be required.

Citing Articles

Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.

Bazazi A, Culbert G, Wegman M, Heimer R, Kamarulzaman A, Altice F BMC Infect Dis. 2022; 22(1):837.

PMID: 36368939 PMC: 9652918. DOI: 10.1186/s12879-022-07804-6.


A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.

Grella C, Ostile E, Scott C, Dennis M, Carnavale J Int J Drug Policy. 2020; 81:102768.

PMID: 32446130 PMC: 8372195. DOI: 10.1016/j.drugpo.2020.102768.


Associated Factors of Maintenance in Patients under Treatment with Methadone: A Comprehensive Systematic Review and Meta-Analysis.

Farmani F, Farhadi H, Mohammadi Y Addict Health. 2019; 10(1):41-51.

PMID: 30627384 PMC: 6312561. DOI: 10.22122/ahj.v10i1.488.


A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis.

Shrestha R, Weikum D, Copenhaver M, Altice F Int J Ment Health Addict. 2017; 15(4):812-825.

PMID: 29051714 PMC: 5642920. DOI: 10.1007/s11469-017-9752-0.


Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia.

Khan F, Krishnan A, Ghani M, Wickersham J, Fu J, Lim S Subst Use Misuse. 2017; 53(2):249-259.

PMID: 28635521 PMC: 5664175. DOI: 10.1080/10826084.2016.1267217.


References
1.
Brands B, Blake J, Marsh D, Sproule B, Jeyapalan R, Li S . The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008; 27(3):37-48. DOI: 10.1080/10550880802122620. View

2.
Lingappa J, Hughes J, Wang R, Baeten J, Celum C, Gray G . Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One. 2010; 5(9):e12598. PMC: 2938354. DOI: 10.1371/journal.pone.0012598. View

3.
Xiao L, Wu Z, Luo W, Wei X . Quality of life of outpatients in methadone maintenance treatment clinics. J Acquir Immune Defic Syndr. 2010; 53 Suppl 1:S116-20. PMC: 2818825. DOI: 10.1097/QAI.0b013e3181c7dfb5. View

4.
Choi P, Kavasery R, Desai M, Govindasamy S, Kamarulzaman A, Altice F . Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010; 21(6):416-23. PMC: 2925151. DOI: 10.1258/ijsa.2009.009180. View

5.
Werb D, Kerr T, Marsh D, Li K, Montaner J, Wood E . Effect of methadone treatment on incarceration rates among injection drug users. Eur Addict Res. 2008; 14(3):143-9. DOI: 10.1159/000130418. View